Moore Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-125,000
Closed -$26.7M 654
2025
Q4
$26.7M Buy
125,000
+35,000
+39% +$7.23M 0.54% 59
2025
Q3
$17.9M Sell
90,000
-30,000
-25% -$5.6M 0.36% 90
2025
Q2
$20.7M Buy
120,000
+30,000
+33% +$4.89M 0.41% 80
2025
Q1
$14M Buy
90,000
+70,000
+350% +$10M 0.47% 70
2024
Q4
$2.75M Sell
20,000
-20,000
-50% -$2.63M 0.05% 297
2024
Q3
$5.97M Buy
+40,000
New +$5.4M 0.17% 200
2023
Q1
Sell
-20,000
Closed -$2.44M 493
2022
Q4
$2.44M Buy
+20,000
New +$2.32M 0.07% 250
2020
Q1
Sell
-37,133
Closed -$5.17M 170
2019
Q4
$5.17M Buy
+37,133
New +$4.13M 0.19% 136

Other funds holding ASND